Evercore ISI upgraded Ventas (NYSE: VTR) from Underperform to In Line with a price target of $59.00 (from $62.00).

Analyst Steve Sakwa comments "We remain cautious on the Healthcare REIT sector in the current environment, as outlined above. However, we view VTR's 12% price decline since 12/18/17 substantially underperforming the REITs -5.46% over the same period as a pivot point where an In Line rating is more appropriate. VTR’s dividend yield of 5.6% vs REIT average is now 161bps points higher than average REIT dividend yield – versus 1 year average of 99bps and 5 year average of 84bps."

For an analyst ratings summary and ratings history on Ventas click here. For more ratings news on Ventas click here.

Shares of Ventas closed at $55.53 yesterday.